Hostname: page-component-758b78586c-qzq9q Total loading time: 0 Render date: 2023-11-29T03:58:58.940Z Has data issue: false Feature Flags: { "corePageComponentGetUserInfoFromSharedSession": true, "coreDisableEcommerce": false, "useRatesEcommerce": true } hasContentIssue false
  • English
  • Français

Elevated Free Fatty Acid is Associated with Cardioembolic Stroke Subtype

Published online by Cambridge University Press:  02 December 2014

Woo-Keun Seo ,
Juyeon Kim ,
Yoo Hwan Kim ,
Ji Hyun Kim ,
Kyungmi Oh ,
Seong-Beom Koh  and
Hong Seok Seo
Woo-Keun Seo*
Affiliation:
Department of Neurology, Korea University Guro Hospital, Korea University, Seouol, Korea
Juyeon Kim
Affiliation:
Department of Neurology, Korea University Guro Hospital, Korea University, Seouol, Korea
Yoo Hwan Kim
Affiliation:
Department of Neurology, Korea University Guro Hospital, Korea University, Seouol, Korea
Ji Hyun Kim
Affiliation:
Department of Neurology, Korea University Guro Hospital, Korea University, Seouol, Korea
Kyungmi Oh
Affiliation:
Department of Neurology, Korea University Guro Hospital, Korea University, Seouol, Korea
Seong-Beom Koh
Affiliation:
Department of Neurology, Korea University Guro Hospital, Korea University, Seouol, Korea
Hong Seok Seo
Affiliation:
Division of Cardiology, Department of Internal Medicine, College of Medicine, Korea University Guro Hospital, Korea University, Seouol, Korea
*
Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, #80, Guro-dong, Guro-gu, Seoul 152-703, Korea.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not possible as this article does not have html content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background and Objectives:

Free fatty acids (FFAs), an important energy substrate, have an association with cardiovascular diseases, such as atherosclerosis, myocardial dysfunction and abnormal cardiac rhythm. However, limited reports are available on the association between FFAs and ischemic stroke. We hypothesized that plasma FFA concentration could be associated with an ischemic stroke, emphasizing the relationship between FFA and subtypes of ischemic stroke.

Methods:

A cross-sectional study examined the association between FFA concentration and subtypes of stroke and cerebral atherosclerosis from a hospital-based acute stroke registry.

Results:

Data of 715 stroke patients were analyzed. The concentration of FFA was highest in the cardioembolic stroke subtype compared with the other stroke subtypes. Logistic regression analysis revealed that an increase in FFA concentration was significantly associated with the cardioembolic subtype after the adjustment of covariates. FFA concentration was also higher in patients with atrial fibrillation (AF) than those without AF. According to the presence of atherosclerotic stenosis, no significantly difference of FFA concentration was found for intracranial and extracranial cerebral arterial atherosclerosis.

Conclusion:

Here we report a significant association between fasting FFA concentration and the cardioembolic stroke subtype. AF is suggested as the mediating factor between FFA and the cardioembolic stroke subtype.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 38 , Issue 6 , November 2011 , pp. 874 - 879
Copyright
Copyright © The Canadian Journal of Neurological 2011

References

1.Pilz, S, Marz, W.Free fatty acids as a cardiovascular risk factor. Clin Chem Lab Med. 2008;46:429–34.Google Scholar
2.Bays, H, Mandarino, L, DeFronzo, RA.Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab. 2004;89:463–78.Google Scholar
3.Oram, JF, Bornfeldt, KE.Direct effects of long-chain non-esterified fatty acids on vascular cells and their relevance to macrovascular complications of diabetes. Front Biosci. 2004;9:1240–53.Google Scholar
4.Opie, LH.The metabolic vicious cycle in heart failure. Lancet. 2004;364:1733–4.Google Scholar
5.Oliver, MF, Opie, LH.Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet. 1994;343:155–8.Google Scholar
6.Shigetoh, Y, Adachi, H, Yamagishi, S, et al.Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens. 2009;22:151–5.Google Scholar
7.Oliver, MF.Sudden cardiac death: the lost fatty acid hypothesis. QJM. 2006;99:701–9.Google Scholar
8.Kurien, VA, Oliver, MF.A metabolic cause for arrhythmias during acute myocardial hypoxia. Lancet. 1970;1:813–15.Google Scholar
9.Taniguchi, A, Nakai, Y, Fukushima, M, et al.Ultrasonographically assessed carotid atherosclerosis in Japanese type 2 diabetic patients: Role of nonesterified fatty acids. Metabolism. 2002;51: 539–43.Google Scholar
10.Sacco, RL, Adams, R, Albers, G, et al.Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association council on stroke: co-sponsored by the council on cardiovascular radiology and intervention: The American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37: 577–617.Google Scholar
11.Go, AS, Hylek, EM, Phillips, KA, et al.Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA. 2001;285: 2370–5.Google Scholar
12.Adams, HP Jr., Bendixen, BH, Kappelle, LJ, et al.Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41.Google Scholar
13.Ay, H, Furie, KL, Singhal, A, Smith, WS, Sorensen, AG, Koroshetz, WJ.An evidence-based causative classification system for acute ischemic stroke. Ann Neurol. 2005;58:688–97.Google Scholar
14.Cocco, G, Chu, D.Rimonabant may induce atrial fibrillation. BMJ. 2009;338:b1061.Google Scholar
15.Leite, CE, Mocelin, CA, Petersen, GO, Leal, MB, Thiesen, FV.Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity. Pharmacol Rep. 2009;61:217–24.Google Scholar
16.Despres, JP, Golay, A, Sjostrom, L.Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med. 2005;353:2121–34.Google Scholar
17.Tansey, MJ, Opie, LH.Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction. Lancet. 1983;2:419–22.Google Scholar
18.Jouven, X, Charles, MA, Desnos, M, Ducimetiere, P.Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation. 2001;104:756–61.Google Scholar
19.Paolisso, G, Gualdiero, P, Manzella, D, et al.Association of fasting plasma free fatty acid concentration and frequency of ventricular premature complexes in nonischemic non-insulin-dependent diabetic patients. Am J Cardiol. 1997;80:932–7.Google Scholar
20.Pilz, S, Scharnagl, H, Tiran, B, et al.Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J Clin Endocrinol Metab. 2006;91:2542–7.Google Scholar
21.Pilz, S, Scharnagl, H, Tiran, B, et al.Elevated plasma free fatty acids predict sudden cardiac death: a 6.85-year follow-up of 3315 patients after coronary angiography. Eur Heart J. 2007;28: 2763–9.Google Scholar
22.Hillered, L, Chan, PH.Effects of arachidonic acid on respiratory activities in isolated brain mitochondria. J Neurosci Res. 1988; 19:94–100.Google Scholar
23.Hillered, L, Chan, PH.Role of arachidonic acid and other free fatty acids in mitochondrial dysfunction in brain ischemia. J Neurosci Res. 1988;20:451–6.Google Scholar
24.Clark, WM, Wechsler, LR, Sabounjian, LA, Schwiderski, UE.Aphase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology. 2001;57:1595–602.Google Scholar
25.Paik, MJ, Li, WY, Ahn, YH, et al.The free fatty acid metabolome in cerebral ischemia following human mesenchymal stem cell transplantation in rats. Clin Chim Acta. 2009;402:25–30.Google Scholar
26.Hart, RG, Pearce, LA, Aguilar, MI.Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–67.Google Scholar
27.Romano, JG, Sacco, RL.Progress in secondary stroke prevention. Ann Neurol. 2008;63:418–27.Google Scholar
28.Bajpai, A, Savelieva, I, Camm, AJ.Treatment of atrial fibrillation. Br Med Bull. 2008;88:75–94.Google Scholar
29.Dobrev, D, Nattel, S.New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet. 2010;375:1212–23.Google Scholar
30.Richieri, GV, Kleinfeld, AM.Unbound free fatty acid levels in human serum. J Lipid Res. 1995;36:229–40.Google Scholar
31.Huang, T, Tucker, KL, Lee, YC, et al.Methylenetetrahydrofolate reductase variants that associated with hypertension and cardiovascular disease interact with dietary polyunsaturated fatty acids to modulate plasma homocysteine in Puerto Rican adults. J Nutr. 2011;141:654–9.Google Scholar
32.Riemersma, RA, Logan, R, Russell, DC, Smith, HS, Simpson, J, Oliver, MF.Effect of heparin on plasma free fatty acid concentrations after acute myocardial infarction. Br Heart J. 1982;48:134–9.Google Scholar